Timeline
More in Software & SaaS
Oxford BioDynamics lands first paid deal for Orion platform
The company said it has signed its first commercial agreement for EpiSwitch Orion, its 3D genomics platform, as part of a UK-funded psoriatic arthritis biomarker programme.